OPKO Health Gross Profit 2010-2024 | OPK

OPKO Health gross profit from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
OPKO Health Annual Gross Profit
(Millions of US $)
2023 $318
2022 $288
2021 $582
2020 $541
2019 $329
2018 $386
2017 $346
2016 $506
2015 $256
2014 $43
2013 $48
2012 $19
2011 $11
2010 $15
2009 $2
OPKO Health Quarterly Gross Profit
(Millions of US $)
2024-09-30 $40
2024-06-30 $52
2024-03-31 $42
2023-12-31 $45
2023-09-30 $48
2023-06-30 $126
2023-03-31 $99
2022-12-31 $56
2022-09-30 $31
2022-06-30 $116
2022-03-31 $85
2021-12-31 $109
2021-09-30 $142
2021-06-30 $150
2021-03-31 $182
2020-12-31 $176
2020-09-30 $155
2020-06-30 $139
2020-03-31 $71
2019-12-31 $82
2019-09-30 $87
2019-06-30 $82
2019-03-31 $78
2018-12-31 $72
2018-09-30 $99
2018-06-30 $114
2018-03-31 $101
2017-12-31 $4
2017-09-30 $95
2017-06-30 $135
2017-03-31 $112
2016-12-31 $12
2016-09-30 $147
2016-06-30 $204
2016-03-31 $144
2015-12-31 $133
2015-09-30 $76
2015-06-30 $28
2015-03-31 $20
2014-12-31 $14
2014-09-30 $9
2014-06-30 $11
2014-03-31 $10
2013-12-31 $9
2013-09-30 $9
2013-06-30 $11
2013-03-31 $20
2012-12-31 $7
2012-09-30 $4
2012-06-30 $4
2012-03-31 $4
2011-12-31 $2
2011-09-30 $3
2011-06-30 $4
2011-03-31 $3
2010-12-31 $8
2010-09-30 $2
2010-06-30 $3
2010-03-31 $2
2009-12-31 $-0
2009-09-30 $0
2009-06-30 $1
2009-03-31 $1
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.078B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $205.491B 25.07
Intuitive Surgical (ISRG) United States $191.931B 100.35
Alcon (ALC) Switzerland $42.651B 28.54
Edwards Lifesciences (EW) United States $41.817B 26.55
IQVIA Holdings (IQV) United States $37.469B 20.64
IDEXX Laboratories (IDXX) United States $36.904B 43.46
DexCom (DXCM) United States $30.627B 46.12
Waters (WAT) United States $23.276B 34.42
STERIS (STE) Ireland $21.284B 24.50
SONOVA HOLDING (SONVY) Switzerland $20.097B 0.00
Hologic (HOLX) United States $17.200B 18.58
Fresenius Medical Care AG KGaA (FMS) Germany $14.078B 14.45
Sysmex ADR (SSMXY) Japan $13.104B 41.09
Globus Medical (GMED) United States $11.291B 28.59
Penumbra (PEN) United States $9.244B 90.55
Masimo (MASI) United States $9.076B 43.92
Teleflex (TFX) United States $8.687B 13.85
Glaukos (GKOS) United States $7.647B 0.00
PROCEPT BioRobotics (PRCT) United States $4.828B 0.00
Integer Holdings (ITGR) United States $4.639B 26.30
Veracyte (VCYT) United States $3.314B 99.44
Inari Medical (NARI) United States $3.126B 0.00
LivaNova (LIVN) United Kingdom $2.714B 15.67
Nihon Kohden (NHNKY) Japan $2.347B 17.83
TransMedics (TMDX) United States $2.344B 74.30
Elekta AB (EKTAY) Sweden $2.216B 19.92
Tandem Diabetes Care (TNDM) United States $2.108B 0.00
Integra LifeSciences Holdings (IART) United States $1.881B 9.83
RxSight (RXST) United States $1.599B 0.00
Alphatec Holdings (ATEC) United States $1.363B 0.00
Artivion (AORT) United States $1.216B 80.56
Pulse Biosciences (PLSE) United States $1.152B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.852B 14.48
Paragon 28 (FNA) United States $0.837B 0.00
Mesa Laboratories (MLAB) United States $0.712B 16.78
ORTHOFIX MEDICAL INC (OFIX) United States $0.699B 0.00
IRadimed (IRMD) United States $0.693B 37.47
AxoGen (AXGN) United States $0.646B 0.00
Pacific Biosciences Of California (PACB) United States $0.597B 0.00
SiBone (SIBN) United States $0.570B 0.00
OrthoPediatrics (KIDS) United States $0.544B 0.00
Semler Scientific (SMLR) United States $0.515B 30.30
Treace Medical Concepts (TMCI) United States $0.493B 0.00
Tactile Systems Technology (TCMD) United States $0.441B 23.84
ClearPoint Neuro (CLPT) United States $0.404B 0.00
Delcath Systems (DCTH) United States $0.370B 0.00
AngioDynamics (ANGO) United States $0.351B 0.00
CVRx (CVRX) United States $0.331B 0.00
NeuroPace (NPCE) United States $0.327B 0.00
Inogen (INGN) United States $0.227B 0.00
Alpha Tau Medical (DRTS) Israel $0.215B 0.00
Accuray (ARAY) United States $0.210B 0.00
Sight Sciences (SGHT) United States $0.203B 0.00
KORU Medical Systems (KRMD) United States $0.187B 0.00
Nevro (NVRO) United States $0.163B 0.00
Atossa Genetics (ATOS) United States $0.157B 0.00
Sensus Healthcare (SRTS) United States $0.143B 15.26
Spectral Diagnostics (EDTXF) Canada $0.105B 0.00
WORK Medical Technology Group (WOK) China $0.094B 0.00
LENSAR (LNSR) United States $0.090B 0.00
Vicarious Surgical (RBOT) United States $0.089B 0.00
Monogram Orthopaedics (MGRM) United States $0.084B 0.00
EDAP TMS S.A (EDAP) France $0.084B 0.00
908 Devices (MASS) United States $0.083B 0.00
InspireMD (NSPR) Israel $0.082B 0.00
Hyperfine (HYPR) United States $0.073B 0.00
Covalon Technologies (CVALF) Canada $0.071B 0.00
EnVVeno Medical (NVNO) United States $0.053B 0.00
Lucid Diagnostics (LUCD) United States $0.048B 0.00
Rapid Micro Biosystems (RPID) United States $0.045B 0.00
Envoy Medical (COCH) United States $0.044B 0.00
Spectral AI (MDAI) United States $0.038B 0.00
Accelerate Diagnostics (AXDX) United States $0.038B 0.00
Neuronetics (STIM) United States $0.035B 0.00
Adagio Medical Holdings (ADGM) United States $0.034B 0.00
Precision Optics (POCI) United States $0.032B 0.00
NexGel (NXGL) United States $0.025B 0.00
DarioHealth (DRIO) United States $0.023B 0.00
Biosig Technologies (BSGM) United States $0.019B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.015B 0.00
Aspira Women's Health (AWH) United States $0.012B 0.00
Baird Medical Investment Holdings (BDMD) $0.012B 0.00
T2 Biosystems (TTOO) United States $0.011B 0.00
QT Imaging Holdings (QTI) United States $0.011B 0.00
PAVmed (PAVM) United States $0.009B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00